Risk of skin cancer after neonatal phototherapy: retrospective cohort study
- David H Brewster1,2,
- Janet S Tucker3,
- Michael Fleming1,
- Carole Morris1,
- Diane L Stockton1,
- David J Lloyd4,
- Sohinee Bhattacharya5,
- James W T Chalmers1,2
- 1Information Services Division, NHS National Services Scotland, Edinburgh, UK
- 2Division of Community Health Sciences, University of Edinburgh, Edinburgh, UK
- 3Obstetrics and Gynaecology, Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, UK
- 4Neonatal Unit, Aberdeen Maternity Hospital, NHS Grampian, Aberdeen, UK
- 5Population Health, Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, UK
- Correspondence to Dr David Brewster, Director, Scottish Cancer Registry, Information Services Division, NHS National Services Scotland, Gyle Square, 1 South Gyle Crescent, Edinburgh EH12 9EB, UK; david.brewster{at}nhs.net
- Accepted 8 April 2010
- Published Online First 23 June 2010
Abstract
Objective To assess the risk of skin cancer in persons treated with neonatal phototherapy (NNPT) for jaundice.
Design Retrospective cohort study.
Setting Grampian Region, Scotland, UK.
Data source Aberdeen Maternity and Neonatal Databank. NNPT exposure was abstracted from paper records spanning 1976–1990. Follow-up to 31 December 2006 by linkage to cancer registration and mortality records.
Main outcome measures Incidence ratios, standardised for age, sex, calendar period and socio-economic position.
Results After excluding neonatal deaths (n=435), the cohort comprised 77 518 persons. 5868 Received NNPT, providing 138 000 person-years at risk (median follow-up, 24 years). Two cases of melanoma occurred in persons exposed to NNPT versus 16 cases in unexposed persons, yielding a standardised incidence ratio of 1.40 (95% CI, 0.17 to 5.04; p=0.834). No cases of squamous cell or basal cell carcinoma of skin were observed in exposed persons.
Conclusions Although there is no statistically significant evidence of an excess risk of skin cancer following NNPT, limited statistical power and follow-up duration mean it is not possible categorically to rule out an effect. However, taken in conjunction with the results of the only other study to investigate risk of melanoma following NNPT, evidence available so far does not suggest a major cause for concern.
Footnotes
-
Funding Supported by a grant from the Chief Scientist Office, Scottish Government Health Directorate (CZG/2/352). The sponsor had no role in study design; collection, analysis and interpretation of data; writing of the manuscript; or the decision to submit the paper for publication.
-
Competing interests None.
-
Provenance and peer review Not commissioned; externally peer reviewed.
